Spots Global Cancer Trial Database for childhood oligodendroglioma
Every month we try and update this database with for childhood oligodendroglioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy | NCT01346267 | Central Nervous... Chemotherapy-in... Unspecified Chi... | Real Acupressur... Placebo Acupres... | 4 Years - 18 Years | University of South Florida | |
| Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors | NCT00052780 | Childhood Centr... Childhood Choro... Childhood Crani... Childhood Epend... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Low-g... Childhood Medul... Childhood Mixed... Childhood Oligo... Childhood Supra... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... | O6-benzylguanin... temozolomide filgrastim pharmacological... laboratory biom... | - 21 Years | National Cancer Institute (NCI) | |
| Carboplatin in Patients With Progressive Gliomas | NCT00002749 | Brain and Centr... | carboplatin | - | Duke University | |
| Tumor Tissue, Blood Samples, and Family History in Predicting Tumor Development and Response to Treatment in Young Patients With Low-Grade Glioma | NCT00891722 | Brain and Centr... | biologic sample... laboratory biom... questionnaire a... | - | National Cancer Institute (NCI) | |
| Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma | NCT00006102 | Brain and Centr... Lymphoma Neuroblastoma Retinoblastoma Sarcoma Unspecified Chi... | becatecarin | - 21 Years | National Cancer Institute (NCI) | |
| Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma | NCT00008008 | Brain and Centr... | filgrastim sargramostim cyclophosphamid... thiotepa autologous bone... bone marrow abl... peripheral bloo... | - | National Cancer Institute (NCI) | |
| Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma | NCT00077207 | Brain Tumor Central Nervous... | carboplatin temozolomide vincristine sul... | - 10 Years | Children's Oncology Group | |
| Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor | NCT00069940 | Brain and Centr... Gastrointestina... Sarcoma | sargramostim telomerase: 540... | 2 Years - | Dana-Farber Cancer Institute | |
| Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors | NCT00002608 | Adrenocortical ... Brain and Centr... Head and Neck C... Liver Cancer Malignant Mesot... Pheochromocytom... Sarcoma | cisplatin doxorubicin hyd... tamoxifen citra... conventional su... radiation thera... | - 65 Years | National Cancer Institute (NCI) | |
| O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors | NCT00003765 | Brain and Centr... | O6-benzylguanin... carmustine | - 21 Years | National Cancer Institute (NCI) | |
| Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy | NCT01346267 | Central Nervous... Chemotherapy-in... Unspecified Chi... | Real Acupressur... Placebo Acupres... | 4 Years - 18 Years | University of South Florida | |
| Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor | NCT00004068 | Brain and Centr... | irinotecan hydr... temozolomide conventional su... radiation thera... | 3 Years - 21 Years | St. Jude Children's Research Hospital | |
| Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas | NCT00276640 | Primary Central... | vincristine, ca... vincristine, ca... radiation thera... | 1 Day - 18 Years | Societe Internationale d'Oncologie Pediatrique | |
| Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma | NCT00070525 | Childhood High-... Childhood Oligo... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... | tipifarnib | - 21 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors | NCT00281905 | Brain and Centr... Neuroblastoma | carboplatin cisplatin cyclophosphamid... methotrexate vincristine sul... radiation thera... | - 3 Years | National Cancer Institute (NCI) | |
| Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy | NCT01346267 | Central Nervous... Chemotherapy-in... Unspecified Chi... | Real Acupressur... Placebo Acupres... | 4 Years - 18 Years | University of South Florida | |
| Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas | NCT00276640 | Primary Central... | vincristine, ca... vincristine, ca... radiation thera... | 1 Day - 18 Years | Societe Internationale d'Oncologie Pediatrique | |
| Radiation Therapy in Treating Young Patients With Gliomas | NCT00238264 | Brain Tumor Central Nervous... | radiation thera... | 3 Years - 20 Years | Children's Oncology Group | |
| Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma | NCT00381797 | Childhood Cereb... Childhood Oligo... Childhood Spina... Recurrent Child... Recurrent Child... Recurrent Child... | Bevacizumab Fludeoxyglucose... Irinotecan Hydr... | - 21 Years | National Cancer Institute (NCI) | |
| TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma | NCT00074334 | Brain and Centr... | TGFa-PE38 immun... conventional su... | 3 Years - 21 Years | Pediatric Brain Tumor Consortium | |
| PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors | NCT01158300 | Brain and Centr... | VEGF inhibitor ... | 3 Years - 21 Years | Pediatric Brain Tumor Consortium | |
| SU5416 in Treating Children With Recurrent or Progressive Brain Tumors | NCT00006247 | Brain and Centr... | semaxanib | - 21 Years | Pediatric Brain Tumor Consortium | |
| Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma | NCT00360945 | Brain and Centr... | cisplatin temozolomide fluorescence in... loss of heteroz... immunohistochem... laboratory biom... radiation thera... | 4 Years - 20 Years | National Cancer Institute (NCI) | |
| Carboplatin in Patients With Progressive Gliomas | NCT00002749 | Brain and Centr... | carboplatin | - | Duke University | |
| Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors | NCT00052780 | Childhood Centr... Childhood Choro... Childhood Crani... Childhood Epend... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Low-g... Childhood Medul... Childhood Mixed... Childhood Oligo... Childhood Supra... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... | O6-benzylguanin... temozolomide filgrastim pharmacological... laboratory biom... | - 21 Years | National Cancer Institute (NCI) | |
| Cilengitide in Treating Children With Refractory Primary Brain Tumors | NCT00063973 | Childhood Centr... Childhood Choro... Childhood Crani... Childhood Epend... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Low-g... Childhood Medul... Childhood Mixed... Childhood Oligo... Childhood Supra... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... | cilengitide laboratory biom... | - 21 Years | National Cancer Institute (NCI) | |
| Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma | NCT00124657 | Brain and Centr... | Erlotinib hydro... | 3 Years - 21 Years | St. Jude Children's Research Hospital | |
| Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial | NCT00890435 | Brain and Centr... Leukemia Unspecified Adu... Unspecified Chi... | questionnaire a... psychosocial as... | 18 Years - | Children's Oncology Group | |
| Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors | NCT00052780 | Childhood Centr... Childhood Choro... Childhood Crani... Childhood Epend... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Low-g... Childhood Medul... Childhood Mixed... Childhood Oligo... Childhood Supra... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... | O6-benzylguanin... temozolomide filgrastim pharmacological... laboratory biom... | - 21 Years | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant Glioma | NCT00107185 | Brain and Centr... | therapeutic aut... | 1 Year - 18 Years | Jonsson Comprehensive Cancer Center | |
| Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor | NCT00069940 | Brain and Centr... Gastrointestina... Sarcoma | sargramostim telomerase: 540... | 2 Years - | Dana-Farber Cancer Institute | |
| Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors | NCT00238173 | Bone Marrow Sup... Brain and Centr... Drug/Agent Toxi... Long-term Effec... | filgrastim acetylcysteine carboplatin cyclophosphamid... etoposide phosp... mannitol sodium thiosulf... | 1 Year - 18 Years | OHSU Knight Cancer Institute | |
| Carboplatin Plus Vincristine in Treating Children and Adolescents With Low Grade Glioma | NCT00003015 | Brain and Centr... | carboplatin vincristine sul... conventional su... radiation thera... | - 15 Years | National Cancer Institute (NCI) | |
| Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas | NCT00276640 | Primary Central... | vincristine, ca... vincristine, ca... radiation thera... | 1 Day - 18 Years | Societe Internationale d'Oncologie Pediatrique | |
| Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial | NCT00890435 | Brain and Centr... Leukemia Unspecified Adu... Unspecified Chi... | questionnaire a... psychosocial as... | 18 Years - | Children's Oncology Group | |
| Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma | NCT00008008 | Brain and Centr... | filgrastim sargramostim cyclophosphamid... thiotepa autologous bone... bone marrow abl... peripheral bloo... | - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
